structural spectroscopic analysis of tumour vasculature pre ......imaging). a green labelled phantom...

1
Structural spectroscopic analysis of tumour vasculature pre and post contrast agent administration Mice were anaesthetized with isofluorane/oxygen inhalation and kept warm using a warm air feedback system. Respiration rate was monitored. Scout images were acquired and slices selected to include tumour. A one dimensional spin-echo pulse sequence was used to obtain spectroscopic data along the length of a 13x1x1 mm prism, as shown in Fig.3 a and b. Images were collected before and 10 min after contrast agent injection. Parameters included TR = 500 ms, TE = 18 ms, prism dimensions 1x1x13 mm, gradient strength 6.5-8.7 G/cm, 1.6 ms sinc pulses, spectral width 100kHz, 512 data points, 512 averages. The distribution of spatial dimensions in the 1D spectra was determined using fineSA software (Osteotronix Ltd, Swansea, UK). These are shown as structural frequency plots in Fig 3 c and d. Results In the individual studies of the physical phantoms it was possible to asses the profile of each phantom. In the multi scan it was possible to see the different profiles according to the different structures of each phantom (and water tube). Background Tumour vasculature is important in the delivery of nutrients and drugs. It is used as a target for some types of therapy and may be modulated as a secondary effect of other cancer treatments. Modelling the uptake of MR contrast agents is widely used to evaluate tumour blood vessels, both before and after treatment. Anti-vascular drugs such as combretastatin-A4 phosphate are sometimes reported to have a large effect on the central regions of tumours while sparing the tumour rim. However, systematic image analysis approaches (either on MRI or autoradiography data) have not consistently demonstrated this effect (1,2). Two features likely to be an advantage in analyzing such data are (i) an automated approach, describing vascular parameters throughout the tumour and (ii) quantitative information about the dimensions of blood vessels and inter-vessel gaps. Structural Spectroscopy TM has been proposed as a technique for characterizing anatomical structures using magnetic resonance data. Data is acquired from rectangular prisms located in the anatomical region and orientation of interest using a novel pulse sequence. The resulting onedimensional signal profiles are then analyzed using customized signal processing algorithms to determine the spacing and/or size distribution of the anatomical elements of interest. To assess the ability of the Structural Spectroscopy technique to characterise those structures and the validity of computer models of those structures physical phantoms are used. The physical phantoms are manufactured with known structures, usually of close packed spheres of polystyrene beads manufactured by Polysciences Inc.. Aims The aims of this study were to compare single and multi phantom scans and to estimate the dimensions of vascular features in animal tumour models using a combination of structural spectroscopy analysis and gadolinium-based MR contrast agents. Methods The phantom studies were carried out in a Varian 7T horizontal bore MR system. Firstly, each phantom was scanned individually in a 12mm 1 H surface coil (m2m Imaging). A green labelled phantom contains microspheres of 180-212μm diameter. A yellow labelled phantom contains microspheres of 355-425μm diameter. Scout images were acquired and slices selected so the prism crossed the phantom. A one dimensional spin- echo pulse sequence was used to obtain spectroscopic data along the length of the 25x3x3 mm prism. The experiment was repeated with a single prism running through a water tube, green and yellow labelled phantoms (and air gaps) placed at the same time and level in the coil. In vivo measurements either before or after gadoteridol (0.1mmol/kg, ProHance, Bracco Imaging) were carried out on cdi nu/nu mice (n=5) implanted on the flank with HT29 human colon carcinoma cells. Measurements were taken 14-21 days after inoculation when the tumours were ~10mm in diameter. Mice had their tail vein cannulated and were restrained within a 33mm 1 H quadrature volume coil (Rapid Biomedical GmbH) in the same Varian 7T horizontal bore MR system. Pre contrast (a and c) showed no apparent structure. However, at 10-14 min post-contrast (b and d) fine structure was revealed at ~12 and 15/mm. For comparison, the noise level (red traces) is shown from regions outside the animal. Conclusions The phantom studies showed that the fineSA software can provide value information regarding several structures within the selected prism/ROI. There was a clear difference in the intensity of structural features seen in HT29 tumours grown in mice after injection of contrast agent (gadoteridol) compared to those before contrast. This is consistent with the highlighting of signals inside and adjacent to perfused tumour blood vessels, the features having spatial dimensions of 50-100 microns. Future studies are planned to evaluate response to treatment and at a range of times after contrast agent injection. References 1. Prise-VE et al., Int J Oncol. 2002 21:717-726. 2. Galbraith-SM et al., J Clin Oncol. 2003 21:2831-2842. G. S. Almeida 1,2 , I. Wilson 1,2 , L. Farr 3 , and R. J. Maxwell 1,2 1 Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom, 2 Newcastle Magnetic Resonance Centre, Newcastle University, Newcastle upon Tyne, United Kingdom, 3 Osteotronix Ltd, Swansea, United Kingdom CR-UK & EPSRC Cancer Imaging Programme at the Universities of Newcastle and Durham in association with the MRC and Department of Health (England) Fig3. Structural spectroscopy in HT29 tumour (a, c) before and (b, d) after injection of gadoteridol (0.1 mmol kg ). 0.00E+00 5.00E+00 1.00E+01 1.50E+01 2.00E+01 2.50E+01 0 2 4 6 8 10 PDF Structural frequency (mm^1) Structural frequency Green Yellow 0 10 20 30 40 50 60 0 0.2 0.4 0.6 0.8 1 PDF Structural scale (mm) Structural scale Green Yellow 0.00E+00 1.00E+01 2.00E+01 3.00E+01 4.00E+01 5.00E+01 6.00E+01 7.00E+01 8.00E+01 0 2 4 6 8 10 Abs Structural frequency (mm^1) Structural frequency Green Yellow Water Air 0 10 20 30 40 50 60 70 80 0 0.2 0.4 0.6 0.8 1 Abs Structural scale (mm) Structural scale Green Yellow Water Air Fig1. Structural spectroscopy in bead phantoms individually.. Fig2. Structural spectroscopy in both bead phantoms and water tube all at once.

Upload: others

Post on 07-Nov-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Structural spectroscopic analysis of tumour vasculature pre ......Imaging). A green labelled phantom contains microspheres of 180-212µm diameter. A yellow labelled phantom contains

Structural spectroscopic analysis of tumour vasculature pre and post contrast agent

administration

Mice were anaesthetized with isofluorane/oxygen inhalation and kept warm using a warm air feedback system. Respiration rate was monitored. Scout images were acquired and slices selected to include tumour. A one dimensional spin-echo pulse sequence was used to obtain spectroscopic data along the length of a 13x1x1 mm prism, as shown in Fig.3 a and b. Images were collected before and 10 min after contrast agent injection. Parameters included TR = 500 ms, TE = 18 ms, prism dimensions 1x1x13 mm, gradient strength 6.5-8.7 G/cm, 1.6 ms sinc pulses, spectral width 100kHz, 512 data points, 512 averages. The distribution of spatial dimensions in the 1D spectra was determined using fineSA software (Osteotronix Ltd, Swansea, UK). These are shown as structural frequency plots in Fig 3 c and d.

Results In the individual studies of the physical phantoms it was possible to asses the profile of each phantom.

In the multi scan it was possible to see the different profiles according to the different structures of each phantom (and water tube).

Background Tumour vasculature is important in the delivery of nutrients and drugs. It is used as a target for some types of therapy and may be modulated as a secondary effect of other cancer treatments. Modelling the uptake of MR contrast agents is widely used to evaluate tumour blood vessels, both before and after treatment. Anti-vascular drugs such as combretastatin-A4 phosphate are sometimes reported to have a large effect on the central regions of tumours while sparing the tumour rim. However, systematic image analysis approaches (either on MRI or autoradiography data) have not consistently demonstrated this effect (1,2).

Two features likely to be an advantage in analyzing such data are (i) an automated approach, describing vascular parameters throughout the tumour and (ii) quantitative information about the dimensions of blood vessels and inter-vessel gaps. Structural SpectroscopyTM has been proposed as a technique for characterizing anatomical structures using magnetic resonance data. Data is acquired from rectangular prisms located in the anatomical region and orientation of interest using a novel pulse sequence. The resulting one‐dimensional signal profiles are then analyzed using customized signal processing algorithms to determine the spacing and/or size distribution of the anatomical elements of interest.

To assess the ability of the Structural Spectroscopy technique to characterise those structures and the validity of computer models of those structures physical phantoms are used. The physical phantoms are manufactured with known structures, usually of close packed spheres of polystyrene beads manufactured by Polysciences Inc..

Aims The aims of this study were to compare single and multi phantom scans and to estimate the dimensions of vascular features in animal tumour models using a combination of structural spectroscopy analysis and gadolinium-based MR contrast agents.

Methods The phantom studies were carried out in a Varian 7T horizontal bore MR system. Firstly, each phantom was scanned individually in a 12mm 1H surface coil (m2m Imaging). A green labelled phantom contains microspheres of 180-212µm diameter. A yellow labelled phantom contains microspheres of 355-425µm diameter. Scout images were acquired and slices selected so the prism crossed the phantom. A one dimensional spin-echo pulse sequence was used to obtain spectroscopic data along the length of the 25x3x3 mm prism. The experiment was repeated with a single prism running through a water tube, green and yellow labelled phantoms (and air gaps) placed at the same time and level in the coil.

In vivo measurements either before or after gadoteridol (0.1mmol/kg, ProHance, Bracco Imaging) were carried out on cdi nu/nu mice (n=5) implanted on the flank with HT29 human colon carcinoma cells. Measurements were taken 14-21 days after inoculation when the tumours were ~10mm in diameter. Mice had their tail vein cannulated and were restrained within a 33mm 1H quadrature volume coil (Rapid Biomedical GmbH) in the same Varian 7T horizontal bore MR system.

Pre contrast (a and c) showed no apparent structure. However, at 10-14 min post-contrast (b and d) fine structure was revealed at ~12 and 15/mm. For comparison, the noise level (red traces) is shown from regions outside the animal.

Conclusions

The phantom studies showed that the fineSA software can provide value information regarding several structures within the selected prism/ROI.

There was a clear difference in the intensity of structural features seen in HT29 tumours grown in mice after injection of contrast agent (gadoteridol) compared to those before contrast. This is consistent with the highlighting of signals inside and adjacent to perfused tumour blood vessels, the features having spatial dimensions of 50-100 microns. Future studies are planned to evaluate response to treatment and at a range of times after contrast agent injection.

References 1. Prise-VE et al., Int J Oncol. 2002 21:717-726. 2. Galbraith-SM et al., J Clin Oncol. 2003 21:2831-2842.

G. S. Almeida 1,2 , I. Wilson 1,2 , L. Farr 3 , and R. J. Maxwell 1,2 1 Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom, 2 Newcastle Magnetic Resonance Centre, Newcastle University, Newcastle upon Tyne, United Kingdom, 3 Osteotronix Ltd, Swansea, United Kingdom

CR-UK & EPSRC Cancer Imaging Programme at the Universities of Newcastle and Durham in association with the MRC and Department of Health (England)

Fig3. Structural spectroscopy in HT29 tumour (a, c) before and (b, d) after injection of gadoteridol (0.1 mmol kg ).

0.00E+00  

5.00E+00  

1.00E+01  

1.50E+01  

2.00E+01  

2.50E+01  

0   2   4   6   8   10  

PDF  

Structural  frequency  (mm^-­‐1)  

Structural  frequency  

Green  

Yellow  

0  

10  

20  

30  

40  

50  

60  

0   0.2   0.4   0.6   0.8   1  

PDF  

Structural  scale  (mm)  

Structural  scale  

Green  

Yellow  

0.00E+00  

1.00E+01  

2.00E+01  

3.00E+01  

4.00E+01  

5.00E+01  

6.00E+01  

7.00E+01  

8.00E+01  

0   2   4   6   8   10  

Abs  

Structural  frequency  (mm^-­‐1)  

Structural  frequency  

Green  

Yellow  

Water  

Air  

0  

10  

20  

30  

40  

50  

60  

70  

80  

0   0.2   0.4   0.6   0.8   1  

Abs  

Structural  scale  (mm)  

Structural  scale  

Green  

Yellow  

Water  

Air  

Fig1. Structural spectroscopy in bead phantoms individually..

Fig2. Structural spectroscopy in both bead phantoms and water tube all at once.